Our meta-analysis demonstrates that XPD Lys751Gln polymorphism significantly increases overall leukemia risk in dominant and heterozygote models, and that this polymorphism is significantly associated with almost all genetic models of childhood and acute leukemia. The gene discussed is ERCC2; the disease is leukemia.